Although some findings suggest that insulin resistance might induce higher CYP2E1 expression and activity in NAFLD [3,32], further studies are required to determine whether this metabolic state specifically affects CYP2E1 targeting to mitochondria. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatotic liver disease.